Probe set for isothermal one-pot reaction for detecting strains with biologically active biosynthetic pathway and uses thereof
US-2024376553-A1 · Nov 14, 2024 · US
US2016145678A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016145678-A1 |
| Application number | US-201414905741-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jul 18, 2014 |
| Priority date | Jul 19, 2013 |
| Publication date | May 26, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides methods and compositions for detecting multiple citrus pathogens using a multiplex branched DNA signal amplification reaction.
Opening claim text (preview).
What is claimed is: 1 . A method for detecting the presence or absence a first citrus pathogen selected from a Huanglongbing, Witches' broom, Citrus Variegated Chlorosis (CVC), and citrus stubborn pathogen in a plant sample, the method comprising: extracting DNA from said sample; performing a multiplex branched DNA signal amplification reaction; wherein the reaction comprises at least one capture extender probe and at least one label extender probe that targets the pathogen, wherein the at least one capture extender probe and the at least one label extender probe each comprises at least 8, 9, or 10 contiguous nucleotides of a probe sequence shown in Table 1; and detecting the presence or absence of a signal above background, wherein the presence of the signal is indicative of the presence of the pathogen in the plants sample. 2 . The method of claim 1 , wherein the reaction comprises multiple capture extender probes and multiple label extender probes that target the pathogen, wherein each of the multiple capture extender probes and multiple label extender probes that target the pathogen comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table 1. 3 . The method of claim 1 or claim 2 , wherein each probe in the reaction that targets the pathogen comprises a probe sequence set forth in Table 1. 4 . The method of claim 1 , wherein the reaction comprises: each capture extender probe, or a variant thereof, shown in Table 1 for the pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the capture extender probe sequence shown in Table 1; and/or each label extender probe, or a variant thereof, shown in Table 1 for the pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the label extender probe sequence shown in Table 1. 5 . The method of any one of claims 1 to 4 , wherein the reaction further comprises a blocking probe shown in Table 1 for the pathogen, or a variant thereof that comprises at least 8, 9, or 10 contiguous nucleotides of the blocking probe sequence as shown in Table 1. 6 . The method of claim 1 , further comprising detecting the presence or absence of a second citrus pathogen, different from the first citrus pathogen, selected from a Huanglongbing, Witches' broom, Citrus canker, CVC, and citrus stubborn pathogen in the plant sample, wherein the reaction comprises at least one capture extender probe and at least one label extender probe that targets the second pathogen wherein the capture extender probe and the label extender probe that target the second pathogen each comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table 1. 7 . The method of claim 6 , wherein the reaction comprises multiple capture extender probes and multiple label extender probes that target the second pathogen, wherein each of the multiple capture extender probes and multiple label extender probes that target the second pathogen comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table 1. 8 . The method of claim 6 or claim 7 , wherein each probe in the reaction that targets the second pathogen comprises a probe sequence as shown in Table 1. 9 . The method of claim 6 , wherein the reaction comprises: each capture extender probe, or a variant thereof, shown in Table 1 for the second pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the capture extender probe sequence shown in Table 1; and/or each label extender probe, or a variant thereof, shown in Table 1 for the second pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the label extender probe sequence shown in Table 1. 10 . The method of any one of claims 6 to 9 , wherein the reaction further comprises a blocking probe shown in Table 1 for the second pathogen, or a variant thereof that comprises at least 8, 9, or 10 contiguous nucleotides of a blocking probe sequence as shown in Table 1. 11 . The method of claim 6 , further comprising detecting the presence or absence of a third citrus pathogen, different from the first and second citrus pathogen, selected from a Huanglongbing, Witches' broom, Citrus canker, CVC, and citrus stubborn pathogen in the plant sample, wherein the reaction comprises at least one capture extender probe and at least one label extender probe that targets the third pathogen, wherein the capture extender probe and the label extender probe that target the third pathogen each comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table 1. 12 . The method of claim 11 , wherein the reaction comprises multiple capture extender probes and multiple label extender probes that target the third pathogen, wherein each of the multiple capture extender probes and multiple label extender probes that target the third pathogen comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table 1. 13 . The method of claim 11 or claim 12 , wherein each probe in the reaction that targets the third pathogen comprise a probe sequence as shown in Table 1. 14 . The method of claim 11 , wherein the reaction comprises: each capture extender probe, or a variant thereof, shown in Table 1 for the third pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the capture extender probe sequence shown in Table 1; and/or each label extender probe, or a variant thereof, shown in Table 1 for the third pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the label extender probe sequence shown in Table 1. 15 . The method of any one of claims 1 to 14 , wherein the reaction further comprises a blocking probe shown in Table 1 for the third pathogen, or a variant thereof that comprises at least 8, 9, or 10 contiguous nucleotides of a blocking probe sequence as shown in Table 1. 16 . The method of claim 11 , further comprising detecting the presence or absence of a fourth citrus pathogen, different from the first, second and third pathogen, selected from a Huanglongbing, Witches' broom, Citrus canker, CVC, and citrus stubborn pathogen in the plant sample, wherein the reaction comprises at least one capture extender probe and at least one label extender probe that targets the fourth pathogen wherein the capture extender probe and the label extender probe that target the fourth pathogen each comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table 1. 17 . The method of claim 16 , wherein the reaction comprises multiple capture extender probes and multiple label extender probes that target the fourth pathogen, wherein each of the multiple capture extender probes and multiple label extender probes that target the fourth pathogen comprise at least 8, 9, or 10 contiguous nucleotides of a probe sequence as shown in Table 1. 18 . The method of claim 16 or claim 17 , wherein each probe in the reaction that targets the fourth pathogen comprises a probe sequence as shown in Table 1. 19 . The method of claim 16 , wherein the reaction comprises: each capture extender probe, or a variant thereof, shown in Table 1 for the fourth pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous nucleotides of the capture extender probe sequence shown in Table 1; and/or each label extender probe, or a variant thereof, shown in Table 1 for the fourth pathogen, wherein the variant comprises at least 8, 9, or 10 contiguous
Expression markers · CPC title
Specific hybridization probes · CPC title
Plant traits · CPC title
for bacteria · CPC title
Primer sets for multiplex assays · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.